BSEInsider Trading / SAST23 Jun 2026 · 23 Jun 2026, 05:30 pm

Closure of trading window for Unaudited Financial Results for the quarter ended 30.06.2026

Gayatri BioOrganics Ltd · 524564

✦ AI Summary

Gayatri BioOrganics Ltd has announced the closure of its trading window for all designated persons, their immediate relatives, and connected persons. This measure is effective from July 1, 2026, and will remain closed until 48 hours after the declaration of the Unaudited Financial Results for the quarter ended June 30, 2026. This action is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, to prevent insider trading. The company will separately intimate the date of the Board Meeting to consider these financial results.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment4/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gayatri BioOrganics Ltd - 524564 - Closure of Trading Window

Attachments (1)

📄

3b54e34e-aa6c-40c4-86bc-2720aedc4bc1.pdf

pdf

Download →
View document text
To, Date: 23.06.2026 The Manager BSE Limited P.J. Towers, Dalal Street Mumbai- 400001 Dear Sir/Madam, Sub: Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 Unit: Gayatri BioOrganics Limited (BSE Scrip Code: 524564) With reference to the subject cited and pursuant to the Company’s Code of Conduct for Prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015 the trading window for dealing in the securities of the Company will remain closed from 01.07.2026 till 48 hours after the declaration of Unaudited Financial Results for the Quarter ending 30.06.2026 for all designated persons, their immediate relatives and all connected persons covered under the Company’s Code of Conduct. The Board Meeting will be scheduled, inter-alia, to consider and approve the Unaudited Financial Results for the quarter ending June 30, 2026. Accordingly, an intimation regarding the notice of Board Meeting shall be sent separately to the Stock Exchange. Further, the designated persons have been intimated not to trade in the securities of the Company during the above said period of closure of trading window. This is for the information and records of the Exchange, please. Thanking you. Yours sincerely, For Gayatri BioOrganics Limited Sreedhara Reddy Kanaparthi Whole-time Director DIN: 09608890